IMO can´t be their vaccines business... entering Phase II and coming possible to market in 2016... they spun off that division in 2012 and are not the only shareholder of that subsidary..
"Current capital of MVC is about US$16.43M, while the major shareholders include MBC, CESCO, and SBC."
IMO also can´t be their second drug "OBP-301 (Compound #), Telomelysin".. at phase I/II.. Shares of license partner didn´t response at all.. (Oncolys BioPharma Inc.)
Sooooo.... what drives the share price up?? New intraday and closing all time high today...
IMO their Nr. 1 drug... PI-88... don´t know if this are expectations of that blockbuster market potential or leaks of "PATRON"....
ATM Progen is valued getting $5million per year for 10years... but the market potential for PI-88 is NOT $50million (royalties on sales >10% for Progen)
Market cap of Medigen ~ A$1.5billion
PGL Price at posting:
88.0¢ Sentiment: None Disclosure: Held
